- Report
- July 2025
- 350 Pages
Global
From €4415EUR$4,949USD£3,822GBP
- Report
- January 2026
- 185 Pages
Global
From €4014EUR$4,500USD£3,476GBP
- Report
- September 2025
- 271 Pages
Global
From €4456EUR$4,995USD£3,858GBP
- Report
- June 2025
- 144 Pages
Global
From €3524EUR$3,950USD£3,051GBP
- Report
- July 2025
- 150 Pages
Global
From €4327EUR$4,850USD£3,746GBP
- Report
- August 2025
- 264 Pages
Global
From €4456EUR$4,995USD£3,858GBP
- Report
- March 2026
- 125 Pages
Global
From €4327EUR$4,850USD£3,746GBP
- Report
- October 2023
- 159 Pages
Global
From €4014EUR$4,500USD£3,476GBP
- Report
- April 2023
- 286 Pages
Global
From €4416EUR$4,950USD£3,823GBP
- Report
- July 2022
- 159 Pages
Global
From €2096EUR$2,350USD£1,815GBP
- Report
- November 2022
- 98 Pages
Global
From €4906EUR$5,500USD£4,248GBP
- Report
- March 2025
- 200 Pages
Global
From €2221EUR$2,490USD£1,923GBP
- Report
- May 2025
- 200 Pages
Europe
From €2221EUR$2,490USD£1,923GBP
- Report
- January 2025
- 256 Pages
Global
From €4014EUR$4,500USD£3,476GBP
- Report
- March 2025
- 147 Pages
Global
From €3567EUR$3,999USD£3,089GBP
- Report
- April 2025
- 209 Pages
Global
From €2230EUR$2,500USD£1,931GBP
- Report
- July 2024
- 141 Pages
Global
From €2230EUR$2,500USD£1,931GBP
From €3122EUR$3,500USD£2,703GBP
- Report
- September 2024
- 82 Pages
India
From €3122EUR$3,500USD£2,703GBP
- Report
- October 2023
- 70 Pages
Egypt
From €3122EUR$3,500USD£2,703GBP

The Respiratory Disorder market within the context of Pulmonary Medicine is a highly specialized field of medicine that focuses on the diagnosis and treatment of diseases and disorders of the lungs and airways. This includes conditions such as asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, pulmonary hypertension, and sleep-disordered breathing. Pulmonologists are the primary healthcare providers for these conditions, and they often work in collaboration with other specialists such as allergists, cardiologists, and thoracic surgeons. Treatment options for respiratory disorders include medications, lifestyle modifications, and in some cases, surgery.
Companies in the Respiratory Disorder market include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more